Drug: |
Imatinib |
|||
---|---|---|---|---|
Trial: |
Five Year Adjuvant Imatinib Mesylate (GleevecĀ®) in Gastrointestinal Stromal Tumor (GIST) (Novartis CSTI571BUS282) |
|||
Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Completed |
Cedars-Sinai Outpatient Cancer Center8700 Beverly Blvd. |
Principal Investigator: |
Charles Forscher, MD |
---|---|
Contact: |
Mimi Lee 310-248-6688 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Cedars-Sinai Outpatient Cancer Center Website: |
http://apps.csmc.edu/SearchClinicalTrials/ |
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.